Lutris Pharma

Improving Anti-Cancer Therapy

Lutris Pharma was founded in 2016, is headquartered in Tel Aviv, Israel, lists 1–10 employees, and has $30.0M in recorded funding across 2 rounds.

Headquarters
Tel Aviv
Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$30.0M
Last Round
$30.0M Series BJan 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Lutris Pharma is a Tel Aviv-based clinical-stage biopharmaceutical company focused on improving the effectiveness and tolerability of anti-cancer therapies. The company develops proprietary treatments designed to reduce the dermatological side effects — such as skin toxicity — that commonly limit dosing and quality of life for oncology patients receiving targeted cancer therapies. Lutris raised $30 million in financing to advance its lead biopharmaceutical program through clinical development.

Summary

Lutris Pharma is a Biotech company based in Tel Aviv, Israel, founded in 2016. It lists 1–10 employees. It has raised $30.0M in total across 2 rounds, most recently a $30.0M Series B round in Jan 2025. Investors include Pontifax, Columbus Venture Partners and Peregrine Ventures.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2025
$30.0M

Sign up to see all 2 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lutris Pharma on Indexed.vc
<a href="https://indexed.vc/companies/lutris-pharma"><img src="https://indexed.vc/api/badge/company/lutris-pharma" alt="Lutris Pharma on Indexed.vc" width="260" height="76" /></a>